Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
8.85
-0.04 (-0.45%)
At close: Jun 26, 2026, 4:00 PM EDT
9.05
+0.20 (2.26%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Xilio Therapeutics Employees
Xilio Therapeutics had 76 employees as of December 31, 2025. The number of employees increased by 12 or 18.75% compared to the previous year.
Employees
76
Change (1Y)
12
Growth (1Y)
18.75%
Revenue / Employee
$703,737
Profits / Employee
-$411,842
Market Cap
54.14M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 76 | 12 | 18.75% |
| Dec 31, 2024 | 64 | -9 | -12.33% |
| Dec 31, 2023 | 73 | -16 | -17.98% |
| Dec 31, 2022 | 89 | 15 | 20.27% |
| Dec 31, 2021 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| aTyr Pharma | 60 |
| Boundless Bio | 28 |
| PDS Biotechnology | 21 |
| Filana Therapeutics | 20 |
| Instil Bio | 17 |
| Lantern Pharma | 16 |
| Context Therapeutics | 15 |
| Eloxx Pharmaceuticals | 10 |
XLO News
- 4 weeks ago - Xilio Therapeutics Registration statement: Registration filing - Filings
- 6 weeks ago - Xilio Therapeutics files $250M mixed securities shelf - TheFly
- 6 weeks ago - Xilio Therapeutics Registration statement: Registration filing - Filings
- 6 weeks ago - Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates - GlobeNewsWire
- 6 weeks ago - Xilio Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Xilio Therapeutics Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Xilio Therapeutics Proxy statement: Proxy filing - Filings